Doximity to Acquire Amion, Leader in Physician Scheduling

Rhea-AI Summary

Doximity (NYSE: DOCS) announced the acquisition of Amion, a top on-call physician scheduling platform, managing nearly 200,000 physician schedules across thousands of hospitals. This strategic move aims to enhance Doximity's physician cloud platform by integrating scheduling capabilities, which will drive engagement across its services. The acquisition is expected to be finalized on April 1, 2022, bridging a decade-long partnership between the two companies. Amion, recognized for its efficiency in scheduling, will leverage Doximity's growth potential to provide improved tools for physicians.

Positive

• Acquisition of Amion enhances Doximity's physician cloud platform.
• Amion manages nearly 200,000 physician schedules, expanding Doximity's service offerings.
• Expected synergies from a decade-long partnership will improve operational efficiency.
• Strengthened engagement across all business units of Doximity.

Negative

• None.

SAN FRANCISCO, Feb. 8, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Amion, a leading on-call physician scheduling site. Amion manages nearly 200,000 physician schedules at thousands of hospitals, including 18 of the top 20.

"We're excited to partner with founder Stuart Karon and the Amion team to expand our physician cloud platform," said Jeff Tangney, CEO and co-founder at Doximity. "Scheduling enhances our collaboration suite and will grow engagement across all our businesses."

"For 24 years, Amion fostered a micro-company model to maximize operational efficiency," said Stuart Karon, CEO and founder at Amion. "We're excited to add Doximity's growth gene to our DNA. Formalizing our decade-long partnership will bring great new tools to many more physicians."

The transaction is expected to close April 1, 2022.

About Amion

Amion is a leading web and mobile on-call scheduling and messaging application for hospitals and physicians. With Amion, groups build balanced, equitable schedules which they post on Amion.com for staff to view and sync work shifts to personal calendars. The mobile application combines scheduling with communication and lets staff submit special requests and swap shifts. Amion founder and CEO Stuart Karon developed an early version of the application in 1998 to help his wife Jodi Wenger, MD, then a chief pediatric resident, build schedules for her large residency training program. Amion is based in the Boston area.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information visit Doximity.com.

Doximity Media Contact:
pr@doximity.com 

View original content:https://www.prnewswire.com/news-releases/doximity-to-acquire-amion-leader-in-physician-scheduling-301478013.html

SOURCE Doximity

FAQ

What did Doximity announce on February 8, 2022?

Doximity announced the acquisition of Amion, a leader in on-call physician scheduling.

What is the expected closing date for the Doximity and Amion acquisition?

The acquisition is expected to close on April 1, 2022.

How many physician schedules does Amion manage?

Amion manages nearly 200,000 physician schedules at thousands of hospitals.

What impact will the acquisition have on Doximity's services?

The acquisition will enhance Doximity's collaboration tools and increase engagement across its platform.

Who are the founders involved in the Doximity-Amion acquisition?

The acquisition involves Doximity's CEO Jeff Tangney and Amion's founder Stuart Karon.